tert-Butyl methyl(2-(methylamino)ethyl)carbamate

CAS: 112257-19-9

Ref. 3D-FB143658

Produktinformation

• Name: tert-Butyl methyl(2-(methylamino)ethyl)carbamate
• CAS: 112257-19-9

Beschreibung

Tert-Butyl methyl(2-(methylamino)ethyl)carbamate (TBMMEC) is an experimental anticancer drug that has been shown to induce the regression of a variety of cancers in animal models. TBMMEC binds to the antigen Cetuximab and its conjugates, which have been found to be effective against colorectal cancer cells. TBMMEC has also been shown to inhibit the replication of human cytomegalovirus, a virus that causes cancer in humans. This drug is currently being tested for safety and efficacy in humans.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 188.27 g/mol
• Formel: C₉H₂₀N₂O₂
• Reinheit: Min. 95%
• Farbe/Form: Colourless To Pale Yellow Liquid
• InChl: InChI=1S/C9H20N2O2/c1-9(2,3)13-8(12)11(5)7-6-10-4/h10H,6-7H2,1-5H3
• InChI Key: InChIKey=DFVRUHANEXOZGT-UHFFFAOYSA-N
• SMILES: CNCCN(C)C(=O)OC(C)(C)C